drugset
drugset / Trial / NCT05140083

68Ga-NOTA Evans Blue PET/CT in Patients With Lymphatic System Related Diseases

NCT05140083 ↗

Phase 1 Unknown 80 enrolled First Affiliated Hospital of Fujian Medical University
NaSingle-groupOpen-labelDiagnostic

Summary

To evaluate the potential usefulness of 68Ga-NOTA Evans Blue (68Ga-NEB) positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and efficacy assessment in lymphatic system related diseases.

Timeline

Start
2021-04-25
Primary completion
2024-12-30
Completion
2024-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-NOTA Evans Blue Diagnostic / imaging agent 37 mbq Subcutaneous
Subject 68Ga-NOTA Evans Blue Diagnostic / imaging agent 111 mbq Subcutaneous

Indications

No indication recorded.